California Healthcare Institute Launches Fourth Podcast Episode On Dangers of a Cost-based U.S. Healthcare System.Former FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Associate Commissioner Examines Why One Size Healthcare Doesn't Fit All LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif. -- The California Healthcare Institute (CHI) today launched the fourth episode of the podcast series, Cost Over Care: The Dangers of Bureaucratic bu·reau·crat n. 1. An official of a bureaucracy. 2. An official who is rigidly devoted to the details of administrative procedure. bu Medicine. As state and federal legislators begin to design their healthcare proposals, this podcast aims to educate policymakers about the dangers of cost-based healthcare initiatives. The five-part series can be found on the California Healthcare Institute Web site, www.chi.org, and is accessible on iTunes and other podcast directories. In the fourth episode, Peter J. Pitts, co-founder and president of the Center for Medicines in the Public Interest and former FDA associate commissioner for external relations, discusses how evidence-based medicine evidence-based medicine Decision-making 'The use of scientific data to confirm that proposed diagnostic or therapeutic procedures are appropriate in light of their high probability of producing the best and most favorable outcome'. See Meta-analysis. has been distorted to institute cost-based healthcare policies. Pitts also explains how these policies can hurt patients' access to the best treatments for their condition. "Why would we entrust the most important thing we have -- our health, our bodies -- to a one-size-fits-all mentality that evidence-based medicine has become in the 21st century?" said Pitts. "The triumph of modern medicine is that it really can be precisely targeted to a certain patient's precise needs." The first episode of the podcast series featured Dr. David Gollaher, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CHI. Additional episodes of the series feature Dr. Kwabena Adubofour, medical director, East Main Clinic and Stockton Diabetes Intervention Center; and Meryl Comer, Emmy-award winning journalist and caregiver. For more information about evidence-based medicine and cost-effectiveness analysis cost-effectiveness analysis Cost-utility analysis Clinical trials A form of economic analysis in which alternative interventions are compared in terms of the cost per unit of clinical effect–eg cost per life saved, per mm Hg of lowered BP, per yr of or to download podcast episodes, please visit the CHI Web site at www.chi.org. This series has been made possible through a grant from Pfizer Inc. California Healthcare Institute (CHI) represents more than 250 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI's web site is http://www.chi.org. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion